Sees Q4 adjusted EBITDA $55M-$65M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims and Hers Health options imply 12.6% move in share price post-earnings
- Options Volatility and Implied Earnings Moves Today, November 03, 2025
- These Are the Stocks Reporting Earnings Today – November 3, 2025
- Hims & Hers Health (HIMS) to Report Q3 Earnings on November 3. Option Traders Expect a 14.94% Move
- HIMS Earnings Report this Week: Is It a Buy, Ahead of Earnings?